Entering text into the input field will update the search result below

Takeda to sell portfolio of assets to Stada for $660M; shares up 4%

  • Following through on its plan to deleverage after the Shire merger, Takeda Pharmaceutical Company (NYSE:TAK +3.6%) has agreed to sell a portfolio of over-the-counter (OTC) and prescription pharmaceutical products sold in Russia, Georgia and certain CIS countries to STADA Arzneimittel AG for $660M. The transaction should close this quarter.
  • The deal is the company's fourth in the last six months as its advances toward its goal of divesting ~$10B in non-core assets.

Recommended For You

About TAK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TAK--
Takeda Pharmaceutical Company Limited